Scholar Rock (SRRK) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

SRRK Stock Forecast

Scholar Rock stock forecast is as follows: an average price target of $40.50 (represents a 53.53% upside from SRRK’s last price of $26.38) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

SRRK Price Target

The average price target for Scholar Rock (SRRK) is $40.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $42.00 to $39.00. This represents a potential 53.53% upside from SRRK's last price of $26.38.

SRRK Analyst Ratings

Buy

According to 4 Wall Street analysts, Scholar Rock's rating consensus is 'Buy'. The analyst rating breakdown for SRRK stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Scholar Rock Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 13, 2024	Etzer Darout	BMO Capital	$39.00	$26.97	44.61%	47.84%
Oct 15, 2024	Allison Bratzel	Piper Sandler	$42.00	$28.52	47.27%	59.21%
Oct 11, 2024	Etzer Darout	BMO Capital	$38.00	$25.27	50.38%	44.05%
Jun 13, 2024	Etzer Darout	BMO Capital	$31.00	$9.39	230.14%	17.51%
May 23, 2024	Allison Bratzel	Piper Sandler	$28.00	$11.18	150.45%	6.14%
May 23, 2024	Etzer Darout	BMO Capital	$29.00	$11.18	159.39%	9.93%

Row per page

Go to

The latest Scholar Rock stock forecast, released on Nov 13, 2024 by Etzer Darout from BMO Capital, set a price target of $39.00, which represents a 44.61% increase from the stock price at the time of the forecast ($26.97), and a 47.84% increase from SRRK last price ($26.38).

Scholar Rock Price Target by Period

	1M	3M	12M
# Anlaysts	1	3	6
Avg Price Target	$39.00	$39.67	$34.50
Last Closing Price	$26.38	$26.38	$26.38
Upside/Downside	47.84%	50.38%	30.78%

In the current month, the average price target of Scholar Rock stock is $39.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 47.84% increase as opposed to Scholar Rock's last price of $26.38. This month's average price target is down -1.69% compared to last quarter, and up 13.04% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 15, 2024	Piper Sandler	Overweight	Overweight	Hold
Oct 11, 2024	BMO Capital	Outperform	Outperform	Hold
Oct 08, 2024	Piper Sandler	Buy	Buy	Hold
Sep 27, 2024	Wedbush	Outperform	Outperform	Hold
Aug 09, 2024	BMO Capital	Outperform	Outperform	Hold
Jun 13, 2024	BMO Capital	Outperform	Outperform	Hold
May 23, 2024	Piper Sandler	Overweight	Overweight	Hold
May 23, 2024	BMO Capital	Outperform	Outperform	Hold
Oct 24, 2023	Jefferies	-	Buy	Upgrade
May 16, 2022	Piper Sandler	Overweight	Overweight	Hold

Row per page

Go to

Scholar Rock's last stock rating was published by Piper Sandler on Oct 15, 2024. The company gave SRRK a "Overweight" rating, the same as its previous rate.

Scholar Rock Financial Forecast

Scholar Rock Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
Revenue	-	-	-	-	-	-	-	$33.19M	-	$5.46M	$4.59M	$4.71M	$3.44M	$3.04M	$3.90M	$5.03M	$7.57M	$4.77M	$5.04M	$3.11M
Avg Forecast	$7.60M	$2.02M	$8.07M	$2.11M	-	-	-	$22.13M	$4.40M	$4.64M	$5.20M	$6.00M	$6.51M	$7.63M	$6.85M	$24.81M	$5.19M	$9.11M	$5.28M	$4.77M
High Forecast	$7.60M	$2.02M	$8.07M	$2.11M	-	-	-	$22.13M	$4.40M	$4.64M	$5.20M	$6.00M	$6.51M	$7.63M	$6.85M	$24.81M	$5.19M	$9.11M	$5.28M	$4.77M
Low Forecast	$7.60M	$2.02M	$8.07M	$2.11M	-	-	-	$22.13M	$4.40M	$4.64M	$5.20M	$6.00M	$6.51M	$7.63M	$6.85M	$24.81M	$5.19M	$9.11M	$5.28M	$4.77M
# Analysts	1	1	1	1	-	-	-	1	1	1	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	1.50%	-	1.18%	0.88%	0.78%	0.53%	0.40%	0.57%	0.20%	1.46%	0.52%	0.95%	0.65%

Scholar Rock's average Quarter revenue forecast for Jun 24 based on 0 analysts is -, with a low forecast of -, and a high forecast of -. SRRK's average Quarter revenue forecast represents a -100.00% decrease compared to the company's last Quarter revenue of $33.19M (Mar 22).

Scholar Rock EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	-	-	-	1	1	1	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	$-6.18M	$-34.64M	$-36.83M	$-30.07M	$-27.08M	$-26.25M	$-23.17M	$-18.89M	$-16.68M	$-11.19M	$-16.31M	$-11.96M	$-10.24M
Avg Forecast	$-4.56M	$-1.21M	$-4.84M	$-1.27M	-	-	-	$-13.28M	$-2.64M	$-2.78M	$-3.12M	$-24.76M	$-3.91M	$-4.58M	$-4.11M	$-405.30M	$-3.12M	$-5.46M	$-3.17M	$-11.88M
High Forecast	$-4.56M	$-1.21M	$-4.84M	$-1.27M	-	-	-	$-13.28M	$-2.64M	$-2.78M	$-3.12M	$-19.81M	$-3.91M	$-4.58M	$-4.11M	$-324.24M	$-3.12M	$-5.46M	$-3.17M	$-9.50M
Low Forecast	$-4.56M	$-1.21M	$-4.84M	$-1.27M	-	-	-	$-13.28M	$-2.64M	$-2.78M	$-3.12M	$-29.71M	$-3.91M	$-4.58M	$-4.11M	$-486.36M	$-3.12M	$-5.46M	$-3.17M	$-14.25M
Surprise %	-	-	-	-	-	-	-	0.47%	13.11%	13.23%	9.64%	1.09%	6.72%	5.06%	4.60%	0.04%	3.59%	2.98%	3.77%	0.86%

undefined analysts predict SRRK's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Scholar Rock's previous annual EBITDA (undefined) of $NaN.

Scholar Rock Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	-	-	-	1	1	1	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	$-8.97M	-	$-37.51M	$-30.71M	$-27.67M	$-26.57M	$-23.56M	$-19.28M	$-17.07M	$-11.57M	$-16.15M	$-12.53M	$-10.76M
Avg Forecast	$-50.74M	$-58.78M	$-57.68M	$-57.12M	$-55.32M	$-56.30M	$-57.16M	$-55.18M	$-95.70M	$-79.00M	$-72.60M	$-25.30M	$-59.06M	$-51.07M	$-50.54M	$-414.80M	$-53.63M	$-29.77M	$-37.11M	$-12.48M
High Forecast	$-50.74M	$-58.78M	$-57.68M	$-44.32M	$-42.70M	$-56.30M	$-57.16M	$-55.18M	$-95.70M	$-79.00M	$-72.60M	$-20.24M	$-59.06M	$-51.07M	$-50.54M	$-331.84M	$-53.63M	$-29.77M	$-37.11M	$-9.98M
Low Forecast	$-50.74M	$-58.78M	$-57.68M	$-65.98M	$-65.02M	$-56.30M	$-57.16M	$-55.18M	$-95.70M	$-79.00M	$-72.60M	$-30.36M	$-59.06M	$-51.07M	$-50.54M	$-497.76M	$-53.63M	$-29.77M	$-37.11M	$-14.97M
Surprise %	-	-	-	-	-	-	-	0.16%	-	0.47%	0.42%	1.09%	0.45%	0.46%	0.38%	0.04%	0.22%	0.54%	0.34%	0.86%

Scholar Rock's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SRRK's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Scholar Rock SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	-	-	-	1	1	1	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	$10.76M	$10.36M	$11.28M	$9.27M	$9.37M	$7.76M	$8.27M	$6.37M	$5.82M	$5.86M	$6.18M	$4.71M	$4.07M
Avg Forecast	$11.07M	$2.95M	$11.76M	$3.08M	-	-	-	$32.25M	$6.42M	$6.76M	$7.58M	$8.75M	$9.49M	$11.12M	$9.98M	$36.16M	$7.57M	$13.27M	$7.70M	$4.72M
High Forecast	$11.07M	$2.95M	$11.76M	$3.08M	-	-	-	$32.25M	$6.42M	$6.76M	$7.58M	$8.75M	$9.49M	$11.12M	$9.98M	$36.16M	$7.57M	$13.27M	$7.70M	$5.67M
Low Forecast	$11.07M	$2.95M	$11.76M	$3.08M	-	-	-	$32.25M	$6.42M	$6.76M	$7.58M	$8.75M	$9.49M	$11.12M	$9.98M	$36.16M	$7.57M	$13.27M	$7.70M	$3.78M
Surprise %	-	-	-	-	-	-	-	0.33%	1.61%	1.67%	1.22%	1.07%	0.82%	0.74%	0.64%	0.16%	0.77%	0.47%	0.61%	0.86%

Scholar Rock's average Quarter SG&A projection for Jun 24 is -, based on 0 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to SRRK last annual SG&A of $10.76M (Mar 22).

Scholar Rock EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	-	-	-	1	1	1	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	$-0.24	-	$-1.02	$-0.84	$-0.76	$-0.89	$-0.79	$-0.65	$-0.58	$-0.39	$-0.55	$-0.48	$-0.42
Avg Forecast	$-0.52	$-0.61	$-0.59	$-0.59	$-0.57	$-0.58	$-0.59	$-0.57	$-0.99	$-0.82	$-0.75	$-0.68	$-0.61	$-0.53	$-0.52	$0.01	$-0.55	$-0.31	$-0.38	$-0.48
High Forecast	$-0.52	$-0.61	$-0.59	$-0.46	$-0.44	$-0.58	$-0.59	$-0.57	$-0.99	$-0.82	$-0.75	$-0.68	$-0.61	$-0.53	$-0.52	$0.01	$-0.55	$-0.31	$-0.38	$-0.48
Low Forecast	$-0.52	$-0.61	$-0.59	$-0.68	$-0.67	$-0.58	$-0.59	$-0.57	$-0.99	$-0.82	$-0.75	$-0.68	$-0.61	$-0.53	$-0.52	$0.01	$-0.55	$-0.31	$-0.38	$-0.48
Surprise %	-	-	-	-	-	-	-	0.42%	-	1.25%	1.12%	1.12%	1.46%	1.50%	1.25%	-48.33%	0.71%	1.79%	1.25%	0.88%

According to undefined Wall Street analysts, Scholar Rock's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SRRK previous annual EPS of $NaN (undefined).

Scholar Rock Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
BCEL	Atreca	$0.09	$4.00	4344.44%	Buy
PASG	Passage Bio	$0.47	$6.00	1176.60%	Buy
HOWL	Werewolf Therapeutics	$1.71	$12.00	601.75%	Buy
BDTX	Black Diamond Therapeutics	$2.50	$14.75	490.00%	Buy
RLAY	Relay Therapeutics	$4.89	$19.40	296.73%	Buy
PLRX	Pliant Therapeutics	$12.32	$39.71	222.32%	Buy
ARVN	Arvinas	$23.19	$71.82	209.70%	Buy
FIXX	Q32 Bio	$0.93	$2.70	190.32%	Buy
ANAB	AnaptysBio	$18.88	$52.00	175.42%	Buy
MLYS	Mineralys Therapeutics	$11.40	$30.00	163.16%	Buy
STOK	Stoke Therapeutics	$11.88	$30.60	157.58%	Buy
CGEM	Cullinan Oncology	$13.45	$31.50	134.20%	Buy
IGMS	IGM Biosciences	$9.22	$20.33	120.50%	Buy
KROS	Keros Therapeutics	$54.01	$102.60	89.96%	Buy
IDYA	IDEAYA Biosciences	$26.19	$46.58	77.85%	Buy
DSGN	Design Therapeutics	$5.76	$9.67	67.88%	Buy
SRRK	Scholar Rock	$26.38	$40.50	53.53%	Buy
MGTX	MeiraGTx	$6.09	$9.00	47.78%	Buy
RNA	Avidity Biosciences	$41.35	$54.50	31.80%	Buy
RVMD	Revolution Medicines, Inc. Warrant	$54.24	$60.63	11.78%	Buy
IKNA	Ikena Oncology	$1.68	$1.33	-20.83%	Buy
CERE	Cerevel Therapeutics	$44.96	$33.50	-25.49%	Buy

SRRK Forecast FAQ

Is Scholar Rock a good buy?

Yes, according to 4 Wall Street analysts, Scholar Rock (SRRK) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 100.00% of SRRK's total ratings.

What is SRRK's price target?

Scholar Rock (SRRK) average price target is $40.5 with a range of $39 to $42, implying a 53.53% from its last price of $26.38. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Scholar Rock stock go up soon?

According to Wall Street analysts' prediction for SRRK stock, the company can go up by 53.53% (from the last price of $26.38 to the average price target of $40.5), up by 59.21% based on the highest stock price target, and up by 47.84% based on the lowest stock price target.

Can Scholar Rock stock reach $40?

SRRK's average twelve months analyst stock price target of $40.5 supports the claim that Scholar Rock can reach $40 in the near future.

What is Scholar Rock's current price target trend?

1 Wall Street analyst forecast a $39 price target for Scholar Rock (SRRK) this month, up 47.84% from its last price of $26.38. Compared to the last 3 and 12 months, the average price target increased by 50.38% and increased by 30.78%, respectively.

What are Scholar Rock's analysts' financial forecasts?

Scholar Rock's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-169M (high $-156M, low $-178M), average SG&A $0 (high $0, low $0), and average EPS is $-1.741 (high $-1.611, low $-1.841). SRRK's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $19.8M (high $19.8M, low $19.8M), average EBITDA is $-11.879M (high $-11.879M, low $-11.879M), average net income is $-224M (high $-212M, low $-233M), average SG&A $28.85M (high $28.85M, low $28.85M), and average EPS is $-2.311 (high $-2.18, low $-2.403).

Did the SRRK's actual financial results beat the analysts' financial forecasts?

Based on Scholar Rock's last annual report (Dec 2021), the company's revenue was $18.82M, which missed the average analysts forecast of $20.24M by -7.06%. Apple's EBITDA was $-127M, beating the average prediction of $-33.306M by 282.20%. The company's net income was $-134M, missing the average estimation of $-273M by -50.96%. Apple's SG&A was $40.27M, beating the average forecast of $29.5M by 36.48%. Lastly, the company's EPS was $-3.64, beating the average prediction of $-3.232 by 12.61%. In terms of the last quarterly report (Mar 2022), Scholar Rock's revenue was $33.19M, beating the average analysts' forecast of $22.13M by 49.98%. The company's EBITDA was $-6.184M, missing the average prediction of $-13.279M by -53.43%. Scholar Rock's net income was $-8.967M, missing the average estimation of $-55.183M by -83.75%. The company's SG&A was $10.76M, missing the average forecast of $32.25M by -66.64%. Lastly, the company's EPS was $-0.24, missing the average prediction of $-0.57 by -57.89%